ORIGINAL RESEARCH article

Front. Oncol., 22 October 2019

Sec. Cancer Molecular Targets and Therapeutics

Volume 9 - 2019 | https://doi.org/10.3389/fonc.2019.01076

RETRACTED: Exosomes Derived From MicroRNA-148b-3p-Overexpressing Human Umbilical Cord Mesenchymal Stem Cells Restrain Breast Cancer Progression

Retracted

A retraction of this article was approved in:

  1. Retraction: Exosomes derived from microRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression

    1. Read retraction
Lei Yuan,Lei Yuan1,2Yuqiong LiuYuqiong Liu1Yunhui QuYunhui Qu1Lan LiuLan Liu1Huixiang Li Huixiang Li1*
  • 1Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  • 2School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Yuan L, Liu Y, Qu Y, Liu L and Li H (2019) Exosomes Derived From MicroRNA-148b-3p-Overexpressing Human Umbilical Cord Mesenchymal Stem Cells Restrain Breast Cancer Progression. Front. Oncol. 9:1076. doi: 10.3389/fonc.2019.01076

Received: 14 March 2019; Accepted: 30 September 2019;
Published: 22 October 2019; Retracted: 14 May 2024.

Edited by:

Anna Rita Migliaccio, Icahn School of Medicine at Mount Sinai, United States

Reviewed by:

Maria Felice Brizzi, University of Turin, Italy
Maria Munoz Caffarel, Biodonostia Health Research Institute (IIS Biodonostia), Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more